WE‐E‐BRB‐09: A GPU‐Based Monte Carlo QA Tool for IMRT and VMAT

Y. Graves, G. Kim, M. Folkerts, T. Teke, I. Popescu, L. Cervino, Z. Tian, X. Jia, S. Jiang

Research output: Contribution to journalArticle

Abstract

Purpose: To develop a GPU‐based Monte Carlo (MC) 3D dosimetry quality assurance (QA) tool employing patient geometry and actual delivery information. Methods: First, we generate fluence maps at all beam angles from the initial treatment plan. A GPU‐based MC dose engine, gDPM, is employed for the secondary dose calculation (SDC) on patient CT. This SDC is used to verify the TPS plan dose (PD) accuracy. Before the 1st treatment fraction, we deliver the treatment plan on a Linac without any phantom setup to obtain machine log files. With the log files, we extract actually delivered fluence maps at all beam angles and perform delivered dose calculation (DDC) using gDPM. The difference between DDC and SDC indicates possible errors in data transferring and machine delivery. Lastly, the comparison between DDC and PD shows the accumulative errors from all the possible sources. Moreover, a web application for this QA tool is developed for clinical use. We have tested this QA tool on 6 patients, 4 VMAT and 2 IMRT patients. We reported mean gamma values and passing rates inside the 20% isodose line; DVH plot and dose difference matrix are also documented. Results: For all six patients, the gamma passing rates within the 20% isodose line for SDC, DDC and PD comparisons are all higher than 95%. In the DVH plot, the three dose distributions were found to be very close. A typical IMRT or VMAT case takes less than one minute to run the whole QA tool. Conclusions: We have developed a GPU‐based MC QA tool which can be used for efficient and easy IMRT and VMAT QA.

Original languageEnglish (US)
Pages (from-to)3957-3958
Number of pages2
JournalMedical Physics
Volume39
Issue number6
DOIs
StatePublished - 2012

Fingerprint

Therapeutics

ASJC Scopus subject areas

  • Biophysics
  • Radiology Nuclear Medicine and imaging

Cite this

Graves, Y., Kim, G., Folkerts, M., Teke, T., Popescu, I., Cervino, L., ... Jiang, S. (2012). WE‐E‐BRB‐09: A GPU‐Based Monte Carlo QA Tool for IMRT and VMAT. Medical Physics, 39(6), 3957-3958. https://doi.org/10.1118/1.4736151

WE‐E‐BRB‐09 : A GPU‐Based Monte Carlo QA Tool for IMRT and VMAT. / Graves, Y.; Kim, G.; Folkerts, M.; Teke, T.; Popescu, I.; Cervino, L.; Tian, Z.; Jia, X.; Jiang, S.

In: Medical Physics, Vol. 39, No. 6, 2012, p. 3957-3958.

Research output: Contribution to journalArticle

Graves, Y, Kim, G, Folkerts, M, Teke, T, Popescu, I, Cervino, L, Tian, Z, Jia, X & Jiang, S 2012, 'WE‐E‐BRB‐09: A GPU‐Based Monte Carlo QA Tool for IMRT and VMAT', Medical Physics, vol. 39, no. 6, pp. 3957-3958. https://doi.org/10.1118/1.4736151
Graves Y, Kim G, Folkerts M, Teke T, Popescu I, Cervino L et al. WE‐E‐BRB‐09: A GPU‐Based Monte Carlo QA Tool for IMRT and VMAT. Medical Physics. 2012;39(6):3957-3958. https://doi.org/10.1118/1.4736151
Graves, Y. ; Kim, G. ; Folkerts, M. ; Teke, T. ; Popescu, I. ; Cervino, L. ; Tian, Z. ; Jia, X. ; Jiang, S. / WE‐E‐BRB‐09 : A GPU‐Based Monte Carlo QA Tool for IMRT and VMAT. In: Medical Physics. 2012 ; Vol. 39, No. 6. pp. 3957-3958.
@article{670490a640754be3b90abc25d33c7d26,
title = "WE‐E‐BRB‐09: A GPU‐Based Monte Carlo QA Tool for IMRT and VMAT",
abstract = "Purpose: To develop a GPU‐based Monte Carlo (MC) 3D dosimetry quality assurance (QA) tool employing patient geometry and actual delivery information. Methods: First, we generate fluence maps at all beam angles from the initial treatment plan. A GPU‐based MC dose engine, gDPM, is employed for the secondary dose calculation (SDC) on patient CT. This SDC is used to verify the TPS plan dose (PD) accuracy. Before the 1st treatment fraction, we deliver the treatment plan on a Linac without any phantom setup to obtain machine log files. With the log files, we extract actually delivered fluence maps at all beam angles and perform delivered dose calculation (DDC) using gDPM. The difference between DDC and SDC indicates possible errors in data transferring and machine delivery. Lastly, the comparison between DDC and PD shows the accumulative errors from all the possible sources. Moreover, a web application for this QA tool is developed for clinical use. We have tested this QA tool on 6 patients, 4 VMAT and 2 IMRT patients. We reported mean gamma values and passing rates inside the 20{\%} isodose line; DVH plot and dose difference matrix are also documented. Results: For all six patients, the gamma passing rates within the 20{\%} isodose line for SDC, DDC and PD comparisons are all higher than 95{\%}. In the DVH plot, the three dose distributions were found to be very close. A typical IMRT or VMAT case takes less than one minute to run the whole QA tool. Conclusions: We have developed a GPU‐based MC QA tool which can be used for efficient and easy IMRT and VMAT QA.",
author = "Y. Graves and G. Kim and M. Folkerts and T. Teke and I. Popescu and L. Cervino and Z. Tian and X. Jia and S. Jiang",
year = "2012",
doi = "10.1118/1.4736151",
language = "English (US)",
volume = "39",
pages = "3957--3958",
journal = "Medical Physics",
issn = "0094-2405",
publisher = "AAPM - American Association of Physicists in Medicine",
number = "6",

}

TY - JOUR

T1 - WE‐E‐BRB‐09

T2 - A GPU‐Based Monte Carlo QA Tool for IMRT and VMAT

AU - Graves, Y.

AU - Kim, G.

AU - Folkerts, M.

AU - Teke, T.

AU - Popescu, I.

AU - Cervino, L.

AU - Tian, Z.

AU - Jia, X.

AU - Jiang, S.

PY - 2012

Y1 - 2012

N2 - Purpose: To develop a GPU‐based Monte Carlo (MC) 3D dosimetry quality assurance (QA) tool employing patient geometry and actual delivery information. Methods: First, we generate fluence maps at all beam angles from the initial treatment plan. A GPU‐based MC dose engine, gDPM, is employed for the secondary dose calculation (SDC) on patient CT. This SDC is used to verify the TPS plan dose (PD) accuracy. Before the 1st treatment fraction, we deliver the treatment plan on a Linac without any phantom setup to obtain machine log files. With the log files, we extract actually delivered fluence maps at all beam angles and perform delivered dose calculation (DDC) using gDPM. The difference between DDC and SDC indicates possible errors in data transferring and machine delivery. Lastly, the comparison between DDC and PD shows the accumulative errors from all the possible sources. Moreover, a web application for this QA tool is developed for clinical use. We have tested this QA tool on 6 patients, 4 VMAT and 2 IMRT patients. We reported mean gamma values and passing rates inside the 20% isodose line; DVH plot and dose difference matrix are also documented. Results: For all six patients, the gamma passing rates within the 20% isodose line for SDC, DDC and PD comparisons are all higher than 95%. In the DVH plot, the three dose distributions were found to be very close. A typical IMRT or VMAT case takes less than one minute to run the whole QA tool. Conclusions: We have developed a GPU‐based MC QA tool which can be used for efficient and easy IMRT and VMAT QA.

AB - Purpose: To develop a GPU‐based Monte Carlo (MC) 3D dosimetry quality assurance (QA) tool employing patient geometry and actual delivery information. Methods: First, we generate fluence maps at all beam angles from the initial treatment plan. A GPU‐based MC dose engine, gDPM, is employed for the secondary dose calculation (SDC) on patient CT. This SDC is used to verify the TPS plan dose (PD) accuracy. Before the 1st treatment fraction, we deliver the treatment plan on a Linac without any phantom setup to obtain machine log files. With the log files, we extract actually delivered fluence maps at all beam angles and perform delivered dose calculation (DDC) using gDPM. The difference between DDC and SDC indicates possible errors in data transferring and machine delivery. Lastly, the comparison between DDC and PD shows the accumulative errors from all the possible sources. Moreover, a web application for this QA tool is developed for clinical use. We have tested this QA tool on 6 patients, 4 VMAT and 2 IMRT patients. We reported mean gamma values and passing rates inside the 20% isodose line; DVH plot and dose difference matrix are also documented. Results: For all six patients, the gamma passing rates within the 20% isodose line for SDC, DDC and PD comparisons are all higher than 95%. In the DVH plot, the three dose distributions were found to be very close. A typical IMRT or VMAT case takes less than one minute to run the whole QA tool. Conclusions: We have developed a GPU‐based MC QA tool which can be used for efficient and easy IMRT and VMAT QA.

UR - http://www.scopus.com/inward/record.url?scp=85024804592&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024804592&partnerID=8YFLogxK

U2 - 10.1118/1.4736151

DO - 10.1118/1.4736151

M3 - Article

C2 - 28520016

AN - SCOPUS:85024804592

VL - 39

SP - 3957

EP - 3958

JO - Medical Physics

JF - Medical Physics

SN - 0094-2405

IS - 6

ER -